A detailed history of Iconiq Capital, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Iconiq Capital, LLC holds 1,016,864 shares of KOD stock, worth $3.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,016,864
Previous 1,016,864 -0.0%
Holding current value
$3.9 Million
Previous $5.35 Million 55.33%
% of portfolio
0.05%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$81.97 - $106.94 $9.21 Million - $12 Million
-112,374 Reduced 9.95%
1,016,864 $97.6 Million
Q4 2020

Feb 12, 2021

SELL
$60.78 - $154.03 $36.5 Million - $92.4 Million
-600,000 Reduced 34.7%
1,129,238 $166 Million
Q2 2020

Aug 14, 2020

SELL
$42.74 - $66.25 $25.6 Million - $39.8 Million
-600,000 Reduced 25.76%
1,729,238 $93.6 Million
Q1 2020

May 15, 2020

SELL
$38.18 - $73.95 $14.5 Million - $28.1 Million
-380,000 Reduced 14.03%
2,329,238 $111 Million
Q3 2019

Nov 15, 2019

BUY
$10.24 - $17.57 $27.7 Million - $47.6 Million
2,709,238 New
2,709,238 $39 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $200M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Iconiq Capital, LLC Portfolio

Follow Iconiq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iconiq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iconiq Capital, LLC with notifications on news.